US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 20.7000
- +1.2500+6.43%
Close Nov 27 16:00 ET
- 19.6700
- -1.0300-4.98%
Post 20:01 ET
109.25MMarket Cap-10454P/E (TTM)
21.0000High18.8100Low90.79KVolume19.1000Open19.4500Pre Close1.81MTurnover3.64%Turnover RatioLossP/E (Static)5.28MShares38.500052wk High22.09P/B51.70MFloat Cap1.400052wk Low--Dividend TTM2.50MShs Float240.0000Historical High--Div YieldTTM11.26%Amplitude1.3695Historical Low19.9630Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Monopar Therapeutics Stock Forum
Cash and Net Loss
Cash and cash equivalents as of September 30, 2024, were $6.0 million. As noted above, the Company completed a registered public offering on October 30, 2024 that yielded net proceeds to the Company of approximately $17.7 million, after deducting placement agent fees and other estimated offering expenses.
Monopar project...
can anyone tell me which stock should I buy to get profit because the onse I've been had they're only giving return of 4 to 5%
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
No comment yet